Delivery Order SPE2DB24D9131-SPE2DB24FXRQ7
Award Date
8/7/24
Potential Completion Date
8/28/24
Potential Value
$7.1K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of NEXPLANON 68 MG IMPLANTS to the Defense Logistics Agency (DLA), a defense agency. The award has a ceiling value of $8,576.28 and is a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of medications and medical supplies to support the recurring medical needs...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of NEXPLANON 68 MG IMPLANTS to the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The firm fixed-price delivery order, valued at $7,146.90, has an ultimate completion date of September 19, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of medications, including branded and generic...
This federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of NEXPLANON 68 MG IMPLANTS. The firm fixed-price contract has a ceiling value of $8,331.72 and a period of performance through July 7, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $8,331.72 firm-fixed-price delivery order is for the supply of NEXPLANON 68 MG IMPLANTS, with a completion date of June 26, 2025. DMS Pharmaceutical Group is an established federal contractor, holding a significant Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999 through November 2026. This IDC enables the DLA to issue delivery...
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA). The contract is a $6,943.10 firm fixed-price delivery order for the supply of 4,568,023,201 units of NEXPLANON 68 MG IMPLANTS, a contraceptive device. The contract has an ultimate completion date of May 14, 2025 and was awarded on April 23, 2025. DMS Pharmaceutical Group holds a $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA under...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $2,858.76 for the supply of NEXPLANON 68 MG IMPLANTS. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $5,002.83 for the procurement of NEXPLANON 68 MG IMPLANTS. The contract is a firm fixed-price award with no set-aside designation, issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain program. DMS Pharmaceutical Group specializes in supplying a wide range of pharmaceutical products and medical supplies to the Department of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of NEXPLANON 68 MG implants to the Defense Logistics Agency Troop Support Medical. The single-award, firm fixed-price delivery order contract has a potential value of $9,290.97 and a completion date of March 6, 2024. DMS Pharmaceutical Group holds a broader indefinite delivery contract, contract 4600082013, with the Defense Logistics Agency under the SPE2DB program, valued up to...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of NEXPLANON 68 MG IMPLANTS to the U.S. Department of Defense (DoD). The contract, valued at $2,858.76, has a completion date of July 3, 2024 and was awarded on June 11, 2024. The contract is a firm fixed-price delivery order under the Medical Supply Chain program of the Defense Logistics Agency (DLA). As a prime vendor, DMS Pharmaceutical Group has an indefinite delivery contract...
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, awarded by the Defense Logistics Agency (DLA), is a firm fixed-price delivery order for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive product. The contract has a ceiling value of $12,583.60 and a completion date of June 27, 2022. This award is part of a larger indefinite delivery contract (IDC) between DMS...